BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11256579)

  • 21. deCODE genetics, Inc.
    Hakonarson H; Gulcher JR; Stefansson K
    Pharmacogenomics; 2003 Mar; 4(2):209-15. PubMed ID: 12605555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating the Comparative Toxicogenomic Database in a Human Pharmacogenomic Resource.
    Calvier FÉ; Bousquet C
    Stud Health Technol Inform; 2020 Jun; 270():267-271. PubMed ID: 32570388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microarrays in pharmacogenomics--advances and future promise.
    Chicurel ME; Dalma-Weiszhausz DD
    Pharmacogenomics; 2002 Sep; 3(5):589-601. PubMed ID: 12223046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developing computational resources in cardiac gene expression.
    Bober MB; Winslow R
    Methods Mol Biol; 2007; 366():253-63. PubMed ID: 17568129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical genomics data standards for pharmacogenetics and pharmacogenomics.
    Shabo A
    Pharmacogenomics; 2006 Mar; 7(2):247-53. PubMed ID: 16515405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Literature-aided interpretation of gene expression data with the weighted global test.
    Jelier R; Goeman JJ; Hettne KM; Schuemie MJ; den Dunnen JT; 't Hoen PA
    Brief Bioinform; 2011 Sep; 12(5):518-29. PubMed ID: 21183478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.
    McDonagh EM; Whirl-Carrillo M; Garten Y; Altman RB; Klein TE
    Biomark Med; 2011 Dec; 5(6):795-806. PubMed ID: 22103613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of structural bioinformatics and traditional Chinese medicine databases in pharmacogenomics.
    Wang JF; Wei DQ
    Pharmacogenomics; 2009 Aug; 10(8):1213-5. PubMed ID: 19663664
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical bioinformatics.
    Chang PL
    Chang Gung Med J; 2005 Apr; 28(4):201-11. PubMed ID: 16013339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoinformatics and chemical genomics: potential utility of in silico methods.
    Valerio LG; Choudhuri S
    J Appl Toxicol; 2012 Nov; 32(11):880-9. PubMed ID: 22886396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs and pharmacogenomics.
    Shomron N
    Pharmacogenomics; 2010 May; 11(5):629-32. PubMed ID: 20415550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenomics of psychiatric drug treatment.
    Mancama D; Arranz MJ; Kerwin RW
    Curr Opin Mol Ther; 2003 Dec; 5(6):642-9. PubMed ID: 14755891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paediatric pharmacogenomics: an overview.
    Hawcutt DB; Thompson B; Smyth RL; Pirmohamed M
    Arch Dis Child; 2013 Mar; 98(3):232-7. PubMed ID: 23196740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multivariate analysis approach to the integration of proteomic and gene expression data.
    Fagan A; Culhane AC; Higgins DG
    Proteomics; 2007 Jun; 7(13):2162-71. PubMed ID: 17549791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression trends and protein features effectively complement each other in gene function prediction.
    Wabnik K; Hvidsten TR; Kedzierska A; Van Leene J; De Jaeger G; Beemster GT; Komorowski J; Kuiper MT
    Bioinformatics; 2009 Feb; 25(3):322-30. PubMed ID: 19050035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomics in anticoagulant drug development.
    Iqbal O
    Pharmacogenomics; 2002 Nov; 3(6):823-8. PubMed ID: 12437483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity.
    Ekins S; Nikolsky Y; Nikolskaya T
    Trends Pharmacol Sci; 2005 Apr; 26(4):202-9. PubMed ID: 15808345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory approval for new pharmacogenomic tests: a comparative overview.
    Joly Y; Koutrikas G; Tassé AM; Issa A; Carleton B; Hayden M; Rieder MJ; Ramos-Paque E; Avard D
    Food Drug Law J; 2011; 66(1):1-24, i. PubMed ID: 24505844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of pharmacogenetics and pharmacogenomics on drug discovery.
    Lindpaintner K
    Nat Rev Drug Discov; 2002 Jun; 1(6):463-9. PubMed ID: 12119748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.